Case 2 (Table I) was not confirmed, but a collagen disease, related to rheumatoid arthritis, was suggested. In one case with rheumatoid arthritis there was a positive L.E.-test indicating the presence of disseminated lupus erythematosus (Case 7, Table II ). All the patients were hospitalized during the study. The duration of prolonged continuous therapy with corticosteroids (cortisone, hydrocortisone, or prednisone) varied from 3 months to 6 years (average 2 years 8 months). In most patients treatment had been started with cortisone or hydrocortisone, which was later on replaced by prednisone when this drug became available. Only one patient was still receiving hydrocortisone at the time of the investigation. The dosage of steroids was in most cases small or moderate (prednisone 5-20 mg. per day). In some cases, however, the dosage of steroids had previously been somewhat higher.
The response of plasma 17,21-dihydroxy-20-ketosteroids(17-OH-CS) to intravenous ACTH drip infusion was used as an index of adrenocortical function or capacity. All drug therapy was stopped one day before the first test. The experiment started at 7.30 to 8.30 a.m., after about 14 hrs' fast. The blood samples were drawn from the cubital vein immediately before the administration of ACTH and 2 and 6 hrs later. The ACTH (ACTHAR, Armour Laboratories, or Cortrophine, Organon) was given by continuous drip infusion in 0 9 per cent. saline or 5 per cent. glucose solution. The dosage was 12-18 I.U. ACTH in 600 to 900 ml. solution over 6 hrs.
Both free and total plasma 17-OH-CS (free+ glucuronidates) were assayed in most instances. The method of Silber and Porter (1954) , as modified by Peterson, Wyngaarden, Guerra, Brodie, and Bunim (1955) and Peterson, Karrer, and Guerra (1957) , was used for the determination of free plasma 17-OH-CS. The total plasma 17-OH-CS was assayed by the procedure developed by Krusius and Oka (1958) . For this purpose 400 units bacterial fl-glucuronidase (Sigma) were dissolved in 1 ml. redistilled water and pipetted to 0 5 ml. I M potassium dihydrophosphate (KH2PO4), 0-3 ml. 5 per cent. sodium bisulphite (NaHSO3), and 5 ml. plasma. The mixture, the pH of which was 6-0 to 6-2, was incubated for 48 hrs at 370 C. The addition of sodium bisulphite was made in order to eliminate any interfering chromogens formed in the presence of glucose during the hydrolysis procedure (Louis, Eiler, Streeten, and Conn, 1956 ).
The adrenocortical capacity was re-estimated in all cases 7 to 14 days after the withdrawal of steroid therapy. A third test was performed in Cases I and 5 (Table I) 30 days after the interruption of the treatment with steroids. Cases I to 5 were kept without hormone therapy between the repeated tests ( Table I ). The other group of five patients (Cases 6 to 10, Table II) received repository intramuscular ACTH injections (Cortrophine-Z, Organon, 20 I.U. twice daily) during the interval between the first and second tests. The plasma 17-OH-CS after 3 days of intramuscular ACTH administration in Cases 6 to 10 was also assayed (Table III, (Krusius, Oka, and Karkeli, 1958) .
Results
The results are presented in Tables I to IV and in the Figure. An impaired adrenocortical response to ACTH was recorded in all cases one day after the withdrawal of steroid therapy. In Case 4, however, the response of plasma 17-OH-CS to ACTH was very near the normal range, despite one year's treatment with 10 mg. prednisone daily. The lowest plasma 17-OH-CS values after 6 hrs' ACTH infusion were obtained in cases which had received a moderate or high dosage of prednisone (Cases 5, 9, and 10). The duration of corticoid treatment seemed to be of less importance, because these cases had been treated for shorter periods than the others. The average plasma 17-OH-CS values in the first adrenocortical capacity test were, in all ten cases, 13-3 3,g. per cent. before ACTH, 18-8 fig. per cent. after 2 hrs, and 21 ,ug. per cent. after 6 hrs of ACTH infusion.
In the group of five patients kept without any medication between the first and second (or third) capacity test (Table I) there was a slight but distinct improvement of adrenocortical response 8 to 14 days after the withdrawal of prednisone, but a normal capacity test was obtained only in Case 4. In two cases the test carried out after 30 days without steroid treatment showed a further improvement of adrenocortical response, the result was entirely normal in only one of them. In none of these patients could any distinct clinical signs of adrenocortical insufficiency be observed.
In all five cases in which intramuscular ACTH injections were given between the first and second test, a normal or raised adrenocortical response was observed 7 to 9 days after the withdrawal of steroid therapy. This was reflected in both the plasma-free and total 17-OH-CS levels. The restoration of the adrenocortical response in this group was very quick, as is shown by the plasma 1 7-OH-CS levels measured after not more than 3 days of intramuscular repository ACTH administration (Table III) . Three of these values were above the lower limit of normal.
The degree and rate of restoration of the adrenocortical capacity differed greatly both in individual cases and in the average estimates in the two groups separately (Figure, opposite) .
Roughly the same changes as in the plasma free 17-OH-CS levels were observed in the plasma total 17-OH-CS levels. The ratio of free to total 17-OH-CS varied only slightly both before the tests and after 2 or 6 hrs of ACTH infusion. Nor did the degree of the adrenocortical response to ACTH have any significant influence on the proportion of free to total 17-OH-CS levels, the ratio being about the same in the first as in the second or third capacity tests (Table IV) . (Sprague and others, 1950; Fraser, Preuss, and Bigford, 1952; Salassa, Bennett, Keating, and Sprague, 1953; Bennett, 1954) .
On the other hand, our results do confirm the clinical observation that it is useful to give ACTH for some days to patients who have been treated for a long time with steroid hormones in order to accelerate the improvement of adrenocortical function. As this improvement is achieved relatively quickly by ACTH administration after the withdrawal of steroid therapy, there seem to be no real indication for simultaneous treatment with steroids and ACTH, as has been suggested (Vasama, Kalliomiki, Vasama, Naatanen, 1957; Young, De Filippis, Meyer, and Wolfson, 1957) .
Our study also shows that the determination of the total 17-OH-CS (free and glucuronidates) in plasma offers no advantages over the determination of free plasma 17-OH-CS, at least in patients with rheumatoid arthritis. The ratio of plasma-free to total 17-OH-CS was constant in all cases, indicating that the conjugation mechanism of 17-OH-CS is not significantly changed either by prolonged steroid therapy or by short-term ACTH administration in patients with rheumatoid arthritis.
Summary
The adrenocortical capacity has been studied in ten patients with rheumatoid arthritis after longterm steroid administration, by measuring the response of plasma-free and total 17-OH-CS to intravenous ACTH infusion. An impaired adrenocortical response was recorded in all these cases one day after the withdrawal of the steroid treatment.
The test was repeated once or twice after an interval of 7 to 30 days in order to investigate the time needed for recovery, after which the capacity test would give a normal result. In five patients who received no further treatment, there was a slight but distinct improvement in the adrenocortical capacity 8 to 14 days after the withdrawal of steroid therapy, but a normal response was obtained in only one case. In two of these cases there was a further improvement of the plasma 17-OH-CS response to ACTH stimulation after 30 days, but in only one was the result quite normal.
The remaining five patients were treated by intramuscular repository ACTH injections between the first and second test in order to hasten the restoration of normal function. In all five a normal or hypernormal adrenocortical capacity was observed group.bmj.com on November 7, 2017 -Published by http://ard.bmj.com/ Downloaded from 7 to 9 days after the withdrawal of steroid therapy. Even after 3 days of ACTH injections the plasma 17-OH-CS level was above the lower limit of normal in three cases out of five.
The ratio of free to total plasma 17-OH-CS varied only slightly in all cases and in all assays performed, indicating that the conjugation mechanism of 17-OH-CS in rheumatoid arthritis is not significantly altered by prolonged corticosteroid or short-term ACTH therapy.
The ACTH preparations used were generously supplied by the Armour and Organon Companies.
The writers are pleased to acknowledge the technical assistance of Miss Elli Sahanen.
Effet du traitement prolonged par des corticosteroldes sur la fonction surrenocorticale Etudes de l'arthrite rhumatismale a la lumiere de la reponse des 17,21-dihydroxy-20-cetosteroides plasmatiques, libres et totaux a la corticotropine intraveineuse REsuME On a etudie la capacity surrenocorticale chez dix malades atteints d'arthrite rhumatismale apres l'administration prolongee de steroides, en mesurant la reponse des 17-OH-CS a l'infusion intraveineuse d'ACTH. Une reponse surrenocorticale affaiblie a etc enregistree dans tous les cas un jour apres l'interruption du traitement steroide.
Cette Efecto del tratamiento prolongado con corticoesteroides sobre la funci6n suprarrenocortical Investigacion de la artritis reumatoide a la luz de la respuesta de los 17,21-dihidroxi-20-cetoesteroides plasmaticos, libres y totales, a la corticotropina intravenosa SUMARIO Se estudi6 la funci6n suprarrenocortical en diez enfermos con artritis reumatoide despues de la administraci6n prolongada de esteroides, midiendo la respuesta de los 17-OH-CS a la infusion endovenosa de ACTH. Una respuesta suprarrenocortical debil fue notada en todos los casos un dia despues de haber cesado el tratamiento esteroide.
El experiment fue repetido una o dos veces, entre 7 y 30 dias despues, para determiner el tiempo necesario para obtener un resultado normal, indicando el restablecimiento de la funci6n. En cinco enfermos hubo una mejoria ligera pero distinta de la funci6n suprarrenal al cabo de 8 a 14 dias despues de la interrupci6n del tratamiento esteroide, pero tan s6lo en uno la respuesta fue normal. En dos de estos casos la respuesta favorable de los 17-OH-CS plasmaticos a la estimulaci6n por el ACTH fue mas pronunciada al cabo de 30 dias, pero solamente uno de ellos di6 un resultado perfectamente normal.
Los demas cinco enfermos fueron tratados con inyecciones de dep6sito intramuscular de ACTH entre el primer y el segundo test, con el fin de acelerar el restablecimiento de la funci6n normal. En 
